ProfileGDS5822 / ILMN_1229492
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 35% 15% 25% 1% 33% 33% 5% 53% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 116.935
GSM1276600PDAC Late Ablation Control 213.315
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 112.525
GSM1276603PDAC Late Ablation 21.61
GSM1276604PDAC Late Ablation 316.633
GSM1303940PDAC Late Ablation_anti-CTLA4 116.333
GSM1303941PDAC Late Ablation_anti-CTLA4 24.25
GSM1303942PDAC Late Ablation_anti-CTLA4 328.253